1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Narcolepsy Treatment Revenue
1.4 Market by Type
1.4.1 Global Narcolepsy Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Sodium Oxybate
1.4.3 Antidepressants
1.4.4 Central Nervous System Stimulants
1.4.5 Others
1.5 Market by Application
1.5.1 Global Narcolepsy Treatment Market Share by Application: 2020 VS 2026
1.5.2 Primary Narcolepsy with Cataplexy
1.5.3 Primary Narcolepsy without Cataplexy
1.5.4 Narcolepsy Due to Medical Conditions
1.5.5 Unspecified Narcolepsy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Treatment Market Perspective (2015-2026)
2.2 Global Narcolepsy Treatment Growth Trends by Regions
2.2.1 Narcolepsy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Narcolepsy Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Narcolepsy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Narcolepsy Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Narcolepsy Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Treatment Players by Market Size
3.1.1 Global Top Narcolepsy Treatment Players by Revenue (2015-2020)
3.1.2 Global Narcolepsy Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Narcolepsy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Narcolepsy Treatment Market Concentration Ratio
3.2.1 Global Narcolepsy Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Narcolepsy Treatment Revenue in 2019
3.3 Narcolepsy Treatment Key Players Head office and Area Served
3.4 Key Players Narcolepsy Treatment Product Solution and Service
3.5 Date of Enter into Narcolepsy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Narcolepsy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Narcolepsy Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Narcolepsy Treatment Market Size by Application (2015-2020)
5.2 Global Narcolepsy Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Narcolepsy Treatment Market Size (2015-2020)
6.2 Narcolepsy Treatment Key Players in North America (2019-2020)
6.3 North America Narcolepsy Treatment Market Size by Type (2015-2020)
6.4 North America Narcolepsy Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Narcolepsy Treatment Market Size (2015-2020)
7.2 Narcolepsy Treatment Key Players in Europe (2019-2020)
7.3 Europe Narcolepsy Treatment Market Size by Type (2015-2020)
7.4 Europe Narcolepsy Treatment Market Size by Application (2015-2020)
8 China
8.1 China Narcolepsy Treatment Market Size (2015-2020)
8.2 Narcolepsy Treatment Key Players in China (2019-2020)
8.3 China Narcolepsy Treatment Market Size by Type (2015-2020)
8.4 China Narcolepsy Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Narcolepsy Treatment Market Size (2015-2020)
9.2 Narcolepsy Treatment Key Players in Japan (2019-2020)
9.3 Japan Narcolepsy Treatment Market Size by Type (2015-2020)
9.4 Japan Narcolepsy Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Narcolepsy Treatment Market Size (2015-2020)
10.2 Narcolepsy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Narcolepsy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Narcolepsy Treatment Market Size by Application (2015-2020)
11 India
11.1 India Narcolepsy Treatment Market Size (2015-2020)
11.2 Narcolepsy Treatment Key Players in India (2019-2020)
11.3 India Narcolepsy Treatment Market Size by Type (2015-2020)
11.4 India Narcolepsy Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Narcolepsy Treatment Market Size (2015-2020)
12.2 Narcolepsy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Narcolepsy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Narcolepsy Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Teva Pharmaceutical
13.1.1 Teva Pharmaceutical Company Details
13.1.2 Teva Pharmaceutical Business Overview
13.1.3 Teva Pharmaceutical Narcolepsy Treatment Introduction
13.1.4 Teva Pharmaceutical Revenue in Narcolepsy Treatment Business (2015-2020))
13.1.5 Teva Pharmaceutical Recent Development
13.2 Takeda
13.2.1 Takeda Company Details
13.2.2 Takeda Business Overview
13.2.3 Takeda Narcolepsy Treatment Introduction
13.2.4 Takeda Revenue in Narcolepsy Treatment Business (2015-2020)
13.2.5 Takeda Recent Development
13.3 Jazz Pharmaceuticals
13.3.1 Jazz Pharmaceuticals Company Details
13.3.2 Jazz Pharmaceuticals Business Overview
13.3.3 Jazz Pharmaceuticals Narcolepsy Treatment Introduction
13.3.4 Jazz Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020)
13.3.5 Jazz Pharmaceuticals Recent Development
13.4 Arena Pharmaceuticals
13.4.1 Arena Pharmaceuticals Company Details
13.4.2 Arena Pharmaceuticals Business Overview
13.4.3 Arena Pharmaceuticals Narcolepsy Treatment Introduction
13.4.4 Arena Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020)
13.4.5 Arena Pharmaceuticals Recent Development
13.5 Graymark Healthcare
13.5.1 Graymark Healthcare Company Details
13.5.2 Graymark Healthcare Business Overview
13.5.3 Graymark Healthcare Narcolepsy Treatment Introduction
13.5.4 Graymark Healthcare Revenue in Narcolepsy Treatment Business (2015-2020)
13.5.5 Graymark Healthcare Recent Development
13.6 Ligand Pharmaceuticals
13.6.1 Ligand Pharmaceuticals Company Details
13.6.2 Ligand Pharmaceuticals Business Overview
13.6.3 Ligand Pharmaceuticals Narcolepsy Treatment Introduction
13.6.4 Ligand Pharmaceuticals Revenue in Narcolepsy Treatment Business (2015-2020)
13.6.5 Ligand Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Teva Pharmaceutical、Takeda、Jazz Pharmaceuticals、Arena Pharmaceuticals、Graymark Healthcare、Ligand Pharmaceuticals
【免責事項】
https://www.globalresearch.jp/disclaimer